Active pharmaceutical ingredient manufacturer Shilpa Medicare plans to merge with Navya Biologicals Private Limited, a company engaged in biologics and biosimilars R&D.
The merger enables both companies to further advance biosimilars development and product process technologies.
Go deeper with GlobalData
Charles River Labs plans to enhance its Biologic Testing Solutions business abilities through the acquisition of Blue Stream Laboratories.
Pursuant to the acquisition, Charles River Labs and Blue Stream Labs will club their biologics capabilities to advance the development of biologics and biosimilar.
Mercal Capital Corporation, a capital pool company, has announced that it will acquire Folia Biotech INC., a clinical stage biopharmaceutical company.
According to the agreement, Mercal plans to acquire all the issued and outstanding shares of Folia by way of securities exchange of its common shares.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
